Galetto Román, Negroni Matteo
Unité de Régulation Enzymatique des Activités Cellulaires, CNRS-URA 2185, Institut Pasteur, Paris, France.
AIDS Rev. 2005 Apr-Jun;7(2):92-102.
The importance of recombination in retroviral evolution has been acknowledged for several decades. Consequently, after the identification of HIV as the etiological agent of AIDS, it was suspected that recombination could also play a central role in the evolution of this virus. However, only recently, extensive epidemiologic studies of HIV infections worldwide have provided an estimate for the occurrence of recombination in vivo, unveiling recombination frequencies that dwarf those initially expected. Nowadays, recombination is regarded as an integral part of the infectious cycle of this retrovirus, which impacts on diagnosis and treatment of infections, especially when genetically distant viruses have been at the origin of the recombinant forms. Retroviral recombination is observed when two genetically divergent genomic RNA molecules are present in the same viral particle, and arises during the reverse transcription step. This review focuses on the mechanisms that have been proposed to account for the occurrence of recombination in retroviruses, from the strand displacement model, according to which recombination occurs during second DNA strand synthesis; to the description of the factors responsible for copy-choice recombination during first DNA strand synthesis, such as the presence of breaks, pause sites, or secondary structures in the genomic RNA. Most of these models have been supported by experimental data obtained from in vitro reconstituted systems or from cell infection studies using academic model sequences. The situation in vivo is expected to be more complex, since several factors come into play when recombination involves relatively distant isolates, as in the case of inter-subtype recombination. At present, it is clear that further studies are needed in order to evaluate whether a prevailing mechanism exists for in vivo recombination, and these studies will also be essential for understanding how the underlying mechanisms of recombination contribute to the evolution of HIV.
几十年来,人们已经认识到重组在逆转录病毒进化中的重要性。因此,在确定HIV为艾滋病的病原体后,人们怀疑重组在这种病毒的进化中也可能发挥核心作用。然而,直到最近,对全球HIV感染的广泛流行病学研究才对体内重组的发生率进行了估计,揭示了重组频率远远高于最初的预期。如今,重组被视为这种逆转录病毒感染周期的一个组成部分,它会影响感染的诊断和治疗,特别是当基因上差异较大的病毒是重组形式的起源时。当两个基因不同的基因组RNA分子存在于同一个病毒颗粒中时,就会观察到逆转录病毒重组,并且在逆转录步骤中发生。这篇综述重点关注了为解释逆转录病毒中重组发生而提出的机制,从链置换模型(根据该模型,重组发生在第二条DNA链合成过程中)到对第一条DNA链合成过程中负责拷贝选择重组的因素的描述,比如基因组RNA中存在断裂、暂停位点或二级结构。这些模型大多得到了从体外重组系统或使用学术模型序列的细胞感染研究中获得的实验数据的支持。体内的情况预计会更复杂,因为当重组涉及相对较远的分离株时,就像亚型间重组的情况,有几个因素会起作用。目前,很明显需要进一步研究以评估体内重组是否存在一种主要机制,并且这些研究对于理解重组的潜在机制如何促进HIV的进化也至关重要。